Acciones Beleave Inc. Canadian Securities Exchange
Acciones
BE
CA0775611084
Farmacéuticos
Ventas 2018 | - | Ventas 2019 | 2,37 3,25 2,22 | Capitalización | 30,37 M 41,51 M 28,4 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -12 M -16,4 M -11,22 M | Resultado Neto 2019 | -33 M -45,11 M -30,86 M | VE / Ventas 2018 | - |
Posición de caja neta 2018 | 5,2 M 7,11 M 4,86 M | Deuda neta 2019 | 10,32 M 14,1 M 9,65 M | VE / Ventas 2019 | 17.137.012 x |
P/E ratio 2018 |
-4,72
x | P/E ratio 2019 |
-0,76
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 98,39 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | - | 26/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Founder | - | 26/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-15,13 % | 4514,3 M | |
-9,75 % | 3154,5 M | |
+2,14 % | 3104,29 M | |
-6,82 % | 2419,24 M | |
+47,87 % | 1968,91 M | |
+0,09 % | 1646,92 M | |
-7,89 % | 1679,28 M | |
-12,97 % | 1529,77 M | |
+33,40 % | 1376,37 M |